Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Pluth
University of Oregon, Department: Other Basic Sciences
Should you be removed from our database? Contact us at [email protected]. Read more below.
Innolyzer, LLC
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Pluth is a professor of chemistry at the University of Oregon. He declares receiving compensation for his work as a chemistry consultant on the scientific advisory board of Innolyzer. He provides expertise on the basic reaction chemistry of hydrogen sulfide (H2S) in the context of developing microfluidic devices for quantifying H2S. He declares that he does not have any voting roles in the company, does not have any role in determining financial priorities or expenditures, and all of his input to Innolyzer is non-binding. This sponsored research proposal states the "primary goal of this technology development proposal is to demonstrate the feasibility of incorporating a molecular receptor into a chemically-modified field effect transistor (ChemFET) device to generate a functional hydrosulfide (HS–) sensor." Given that Innolyzer is in a line of business that stands to directly benefit from this research; Dr. Pluth's past and ongoing relationship with Innolyzer; and the expectation that findings from this research will be applied to new products and services, there is an apparent and potential financial conflict of interest for Dr. Pluth's involvement with this research.
A Sensor for quantification of hydrogen sulfide
Project Narrative Hydrogen sulfide (H2S) is a gasotransmitter that is involved in the regulation of different cellular processes, and its misregulation is associated with human health conditions ranging from diabetes and hypertension to inflammation and neurodegeneration. Due to the lack sensitive and rapid methods to quantify H2S levels in vivo or in vitro, precise information is missing regarding the actual H2S levels that may be indicative of certain disease states. Using a recently-developed pioneering class of receptors that bind HS? (the most prevalent form of H2S under physiological conditions) reversibly, the assembled team aims to integrate this novel approach into ChemFET architectures to develop new H2S/HS? measurement devices.
Filed on October 18, 2018.
Tell us what you know about Michael Pluth's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.